Skip to main content
Clinical Trials/NCT02039102
NCT02039102
Completed
Not Applicable

Use of Hormonal Contraceptives in Relation to Asthma and Wheezing Disorders in Scottish Women: a Population-based Cross-sectional Survey

University of Edinburgh1 site in 1 country3,257 target enrollmentDecember 2013
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
University of Edinburgh
Enrollment
3257
Locations
1
Primary Endpoint
Self-reported doctor-diagnosed current asthma
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Studies examining the sex differences in the epidemiology and morbidity patterns of asthma show that the rates of disease severity, healthcare utilisation, and poor quality of life are considerably higher in women than in men, and this has been attributed to endogenous and exogenous sex hormonal factors. Studies examining the impact of use of hormonal contraceptives on the risk of asthma and asthma-related conditions are few, yet findings are conflicting.

In the present study, the investigators utilize data from the Scottish Health Survey, a national representative sample, to investigate the associations between current use of hormonal contraceptives and the prevalence of self-reported doctor-diagnosed current asthma and wheezing symptoms in Scottish women. The investigators hypothesize that while current use of any hormonal contraceptives and combined oral pills are associated with higher prevalence of asthma and asthma outcomes, current use of progesterone-only contraceptives is not associated with asthma. A secondary aim of the current study is to examine whether there is evidence of any biological interaction between use of hormonal contraceptives and BMI in relation to the risk of asthma and asthma outcomes.

Registry
clinicaltrials.gov
Start Date
December 2013
End Date
September 2018
Last Updated
4 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Non-pregnant
  • 16-45 years old

Exclusion Criteria

  • Younger than 16 years or older than 45 years old

Outcomes

Primary Outcomes

Self-reported doctor-diagnosed current asthma

Time Frame: During the past 12 months

Secondary Outcomes

  • Self-reported wheezing symptom(During the past 12 months)
  • Self-reported current treatment for asthma/wheeze(During the past 12 months)

Study Sites (1)

Loading locations...

Similar Trials